Related Experiment Video
Updated: Nov 3, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Long non-coding RNA XIST regulates ovarian cancer progression via modulating miR-335/BCL2L2 axis
Qingjuan Meng1, Ningning Wang2, Guanglan Duan3
1Medical Examination Center, The Third Hospital of Jinan, Jinan, 250132, China.
Background:
X inactivation-specific transcript (XIST) is the long non-coding RNA (lncRNA) related to cancer, which is involved in the development and progression of various types of tumor. However, up to now, the exact role and molecular mechanism of XIST in the progression of ovarian cancer are not clear. We studied the function of XIST in ovarian cancer cells and clinical tumor specimens.
Methods:
RT-qPCR was performed to detect the expression levels of miR-335 and BCL2L2 in ovarian cancer cells and tissues. MTT and transwell assays were carried out to detect cell proliferation, migration, and invasion abilities. Western blot was performed to analyze the expression level of BCL2L2. The interaction between miR-335 and XIST/BCL2L2 was confirmed using a luciferase reporter assay.
Results:
The inhibition of XIST can inhibit the proliferation invasion and migration of human ovarian cancer cells. In addition, the miR-335/BCL2L2 axis was involved in the functions of XIST in ovarian cancer cells. These results suggested that XIST could regulate tumor proliferation and invasion and migration via modulating miR-335/BCL2L2.
Conclusion:
XIST might be a carcinogenic lncRNA in ovarian cancer by regulating miR-335, and it can serve as a therapeutic target in human ovarian cancer.
Insights
XIST long non-coding RNA (lncRNA) promotes ovarian cancer progression by regulating the miR-335/BCL2L2 axis. Inhibiting XIST suppressed tumor growth and metastasis, identifying XIST as a potential therapeutic target for ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- X inactivation-specific transcript (XIST) is a long non-coding RNA implicated in various cancers.
- The precise role of XIST in ovarian cancer progression remains unclear.
- This study investigates XIST function in ovarian cancer cells and tissues.
Purpose of the Study:
- To elucidate the function and molecular mechanism of XIST in ovarian cancer.
- To determine if XIST influences ovarian cancer cell proliferation, migration, and invasion.
- To explore the involvement of the miR-335/BCL2L2 axis in XIST-mediated ovarian cancer progression.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) to measure miR-335 and BCL2L2 expression.
- Cell proliferation, migration, and invasion assays (MTT, Transwell).
- Western blot for BCL2L2 protein levels and luciferase reporter assays to confirm molecular interactions.
Main Results:
- Inhibition of XIST significantly reduced ovarian cancer cell proliferation, invasion, and migration.
- The miR-335/BCL2L2 axis was identified as a key mediator of XIST's effects.
- XIST regulates tumor progression through modulation of the miR-335/BCL2L2 pathway.
Conclusions:
- XIST acts as a carcinogenic lncRNA in ovarian cancer.
- XIST promotes ovarian cancer development by regulating miR-335.
- XIST represents a promising therapeutic target for ovarian cancer treatment.
Related Concept Videos
Inheritance of Chromatin Structures
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Epigenetic Regulation
